NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prolate | OXYCODONE AND ACETAMINOPHEN | Forte Bio-Pharma LLC | 9cbbfa94-37b9-9652-e053-2995a90a736b | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Mucinex Fast-Max Cold, Flu and Sore Throat Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 7050b583-c09b-4457-9a9c-70c0923b62c0 | 2026-05-19 | Warnings | 362O9ITL9D |
| Mucinex Fast-Max Cold and Flu Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 27312ee4-d1f4-4a95-9c45-91fa5a01f5ba | 2026-05-19 | Warnings | 362O9ITL9D |
| Mucinex Rapid Clear Daytime Pain, Headache, and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Reckitt Benckiser LLC | 37de53a7-5546-3804-e063-6294a90a0fb5 | 2026-05-19 | Warnings | 362O9ITL9D |
| Mucinex Fast-Max Congestion and Headache Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | d7017328-f8af-4601-9232-dc1104feaa0a | 2026-05-19 | Warnings | 362O9ITL9D |
| Mucinex Rapid Clear Pain Headache and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Reckitt Benckiser LLC | 32375b12-75ed-d605-e063-6294a90ad004 | 2026-05-19 | Warnings | 362O9ITL9D |
| Mucinex Sinus-Max Pressure, Pain and Cough Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 07da45b5-d05e-41b1-b233-f7034d556a8d | 2026-05-19 | Warnings | 362O9ITL9D |
| Mucinex Sinus-Max Severe Congestion and Pain Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | ad4e0e4d-cc1f-4176-835f-3ba76564c634 | 2026-05-19 | Warnings | 362O9ITL9D |
| Mucinex Childrens Mini Melts Cold and Flu | ACETAMINOPHEN AND GUAIFENESIN | Reckitt Benckiser LLC | 401fe0a0-ec97-5248-e063-6394a90af27f | 2026-05-19 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ST. MARY'S MEDICAL PARK PHARMACY | 3d347b9b-1b5c-68c8-e063-6294a90aaa9b | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| Phenohytro | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, AND SCOPOLAMINE HYDROBROMIDE | ATLANTIC BIOLOGICALS CORP. | a5aaf1db-1938-4073-9da4-c47f959d013e | 2026-05-19 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Smart Care Hand Sanitizer with Beaded Wristlet Lily Water | ALCOHOL | Shenzhen Lantern Scicence Co.,Ltd. | 523a8084-a67b-77da-e063-6394a90a4ff9 | 2026-05-19 | Warnings | M003 3K9958V90M |
| METOPROLOL TARTRATE | METOPROLOL TARTRATE | A-S Medication Solutions | ef6a817b-58c5-45bc-b5a2-22c31b05c0ab | 2026-05-19 | Warnings, Adverse reactions | 866514 W5S57Y3A5L |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Topco Associates, LLC | 62f03f3c-8475-40bd-a5e4-ec9292b74785 | 2026-05-19 | Warnings | 362O9ITL9D |
| METOPROLOL TARTRATE | METOPROLOL TARTRATE | A-S Medication Solutions | 2bcfb9d9-e092-4a0a-ac55-bad532de360c | 2026-05-19 | Warnings, Adverse reactions | 866514 W5S57Y3A5L |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Sandoz Inc | 8bd72c1e-2751-4498-a346-bc5e3acbba0b | 2026-05-19 | Warnings, Adverse reactions | 797544 |
| Dentaforce | ANTIMONIUM CRUDUM, BELLADONNA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, HEKLA LAVA, MERCURIUS SOLUBILIS, PLUMBUM METALLICUM, SEPIA, SILICEA, HYDROFLUORICUM ACIDUM | BioActive Nutritional, Inc. | 82321547-e04a-42ff-aa39-6a192638e5a2 | 2026-05-18 | Warnings | ETJ7Z6XBU4 |
| GOOD SENSE DAYTIME | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | L. Perrigo Company | 2597e84c-18b4-41a9-8e6a-ff0c4c1f0612 | 2026-05-18 | Warnings | 362O9ITL9D |
| Atropine Sulfate | ATROPINE SULFATE | Hospira, Inc. | ad8916e7-206e-409e-2582-30d072845dd4 | 2026-05-18 | Warnings, Adverse reactions | NDA021146 0409-4910 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.